Altre lingue GlucoTrack, Inc.

Azioni

GCTK

US45824Q5071

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 10/05/2024			Variaz. 5gg	Var. 1 gen.
0,5602 ^USD	-0,50%		-8,16%	+114,23%

16/04	GlucoTrack, Inc. annuncia l'espansione della sua tecnologia di monitoraggio del glucosio continuo al monitoraggio del glucosio epidurale	CI
02/04	Glucotrack annuncia l'aumento della longevità del sensore per il suo monitor impiantabile continuo del glucosio nel sangue	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION	02/05
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT	22/04
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK	22/04
GlucoTrack, Inc. announced that it has received $0.5 million in funding	22/04
Glucotrack Expanding Glucose Monitoring Technology to Epidural Space	16/04
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING	16/04
GlucoTrack, Inc. Announces Expansion of its Continues Glucose Monitoring Technology to Epidural Glucose Monitoring	16/04
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR	02/04
Glucotrack Announces Increased Sensor Longevity for Its Implantable Continuous Blood Glucose Monitor	02/04
GlucoTrack, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
GLUCOTRACK EXPANDS LEADERSHIP TEAM WITH NEW VICE PRESIDENT OF QUALITY	12/03
GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR	27/02
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS	13/02
Glucotrack, Inc Announces Appointment of Luis Malavé as Chairman of Its Board of Directors	13/02
GlucoTrack Inc. : GlucoTrack veröffentlicht die ersten Daten zur Messgenauigkeit seines implantierbaren Geräts für die kontinuierliche Glukoseüberwachung	08/02
GlucoTrack Says Implantable Glucose Monitor Safe With High Level of Accuracy; Shares Rise	02/01
GlucoTrack, Inc. Announces Early Accuracy Data for its Implantable Continuous Glucose Monitor	02/01
GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR	02/01
GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT	30/11
GlucoTrack, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue GlucoTrack, Inc.

Azioni

GCTK

US45824Q5071

Altre lingue

Filtri